))
Weight management medication semaglutide (Wegovy) for heart failure - what do new data in people with diabetes teach us?
Manage episode 412755790 series 3546736
Contenu fourni par Dr. Sue Pedersen. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr. Sue Pedersen ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Semaglutide 2.4mg (Wegovy) has now been shown to effectively treat symptoms of heart failure in people with or without diabetes. What do the new data teach us?
Learn more: https://drsue.ca/2024/04/weight-management-medication-semaglutide-wegovy-for-heart-failure-what-do-new-data-in-people-with-diabetes-teach-us/
Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.
37 episodes
Partager
